Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 44 | 0 | 1 | 0 | €244.10 | €275.25 | 12.761% |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | €14.05 | €29.92 | 112.997% |
| Jazz Pharmaceuticals plc | 33 | 0 | 3 | 0 | €99.66 | €182.69 | 83.312% |
| United Therapeutics | 29 | 1 | 2 | 0 | €324.20 | €341.89 | 5.455% |
| Ultragenyx Pharmaceutical Inc. | 29 | 1 | 5 | 0 | €49.00 | €82.93 | 69.247% |
| Icon plc | 27 | 0 | 5 | 0 | €267.30 | €327.46 | 22.507% |
| Halozyme Therapeutics Inc. | 25 | 0 | 4 | 0 | €53.94 | €58.58 | 8.598% |
| Merit Medical Systems | 24 | 0 | 3 | 0 | €87.00 | €90.63 | 4.177% |
| Exelixis Inc. | 22 | 0 | 4 | 0 | €23.95 | €26.01 | 8.586% |
| Medpace Holdings Inc | 18 | 0 | 2 | 0 | €312.60 | €408.19 | 30.578% |
| Xencor Inc. | 17 | 0 | 1 | 0 | €17.40 | €31.37 | 80.259% |
| Insulet Corp. | 17 | 0 | 3 | 0 | €209.50 | €216.95 | 3.557% |
| Alkermes plc | 18 | 2 | 1 | 0 | €25.20 | €35.60 | 41.288% |
| Repligen Corp. | 15 | 0 | 1 | 0 | €131.60 | €183.52 | 39.450% |
| LivaNova plc | 15 | 0 | 3 | 0 | €47.80 | €66.25 | 38.600% |
| CONMED Corp. | 16 | 1 | 1 | 0 | €60.50 | €97.67 | 61.435% |
| Amedisys Inc. | 11 | 0 | 0 | 0 | €85.50 | €92.26 | 7.906% |
| PTC Therapeutics Inc. | 17 | 6 | 2 | 0 | €31.00 | €41.81 | 34.878% |
| QIAGEN NV | 10 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Agios Pharmaceuticals Inc. | 11 | 1 | 2 | 0 | €36.80 | €49.07 | 33.349% |
| Bio-Techne Corp. | 9 | 0 | 0 | 0 | €71.00 | €75.94 | 6.952% |
| Amicus Therapeutics Inc. | 9 | 0 | 2 | 0 | €9.45 | €17.63 | 86.582% |
| Ensign Group Inc. | 9 | 0 | 1 | 0 | €132.00 | €125.13 | -5.204% |
| Masimo Corp. | 8 | 0 | 1 | 0 | €126.55 | €149.32 | 17.993% |